Clinical Trial: A Study to Learn How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Compared to Rituximab and Chemotherapy in Adult Participants With Previously Untreated Follicular Lymphoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Follicular Lymphoma (FL)
Study Type: INTERVENTIONAL
Official Title: A Phase 3, Open-Label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20x Anti-CD3 Bispecific Antibody, Combined With Chemotherapy Versus Rituximab Combined
Brief Summary:
This study is researching an experimental drug called odronextamab, referred to as study drug.The study is focused on participants with previously untreated follicular lymphoma in Part 2, as well as participants with lymphoma that has come back after treatment (called "relapsed") or did not respond to treatment (called "refractory"), in Part 1. Follicular lymphoma is a type of non-Hodgkin lymphoma or NHL.This study is made up of 3 parts: Part 1A (non-randomized), Part 1B and Part 2 (randomized…
Read more